1031 - 1040 of 8137 Results
Title
Year
-
RESTRICTEDTitle: Patterns of TDP‐43 Deposition in Brains with LRRK2 G2019S MutationsJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 8Start Page: 1541End Page: 1545Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29449Citation Count: 5
-
OPENTitle: Association of sulfonylureas with the risk of dementia: A population‐based cohort studyJournal Name: Journal of the American Geriatrics SocietyPublisher: WileyVol: 71Issue #: 10Start Page: 3059End Page: 3070Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/jgs.18397Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jgs.18397Citation Count: 19
- Estimated glomerular filtration rate is a biomarker of cognitive impairment in Parkinson’s disease2023OPENTitle: Estimated glomerular filtration rate is a biomarker of cognitive impairment in Parkinson’s diseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2023.1130833Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2023.1130833/pdfCitation Count: 5
-
RESTRICTEDTitle: Brain Calcifications: Genetic, Molecular, and Clinical AspectsJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 24Issue #: 10Start Page: 8995End Page: 8995Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms24108995Best OA location URL: https://www.mdpi.com/1422-0067/24/10/8995/pdf?version=1684484473Citation Count: 3
-
OPENTitle: Status of Current Biofluid Biomarkers in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13753Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13753Citation Count: 4
- Association of Cortical and Subcortical Microstructure With Clinical Progression and Fluid Biomarkers in Patients With Parkinson Disease2023OPENTitle: Association of Cortical and Subcortical Microstructure With Clinical Progression and Fluid Biomarkers in Patients With Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 101Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000207408Citation Count: 10
-
OPENTitle: Assortative mixing in micro-architecturally annotated brain connectomesJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-023-38585-4Best OA location URL: https://www.nature.com/articles/s41467-023-38585-4.pdfCitation Count: 12
- Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) Dimerization2023OPENTitle: Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) DimerizationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 11Start Page: 1971End Page: 1980Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.3c00259Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.3c00259Citation Count: 17
-
OPENTitle: Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 146Issue #: 1Start Page: 51End Page: 75Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-023-02585-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-023-02585-x.pdfCitation Count: 18
-
RESTRICTEDTitle: Valbenazine as treatment for Huntington's disease choreaJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 6Start Page: 459End Page: 460Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00163-1Citation Count: 3